The dysregulation of the inflammasome complex can also influence the prognosis of patients, since studies report that the constitutive activation of NLRP3 seems to cleave the glucocorticoid receptor, this being the first line of treatment for ALL, and thus increase the number of relapses9,10. Here, NR3C1 is linked to acute lymphoblastic leukemia.